首頁 > 市場調查報告書 > 醫療設備

泌尿科

市場調查報告書

商品編碼

1618253

泌尿系統設備:市場洞察·競爭環境·市場預測 (～2030年)

Urology Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日期: 2024年12月01日 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

泌尿器械市場規模預計將從 2023 年的 91.7 億美元增長到 2030 年的 135.6 億美元，預測期內複合年增長率為 6.78%。

泌尿設備市場的推動因素包括越來越多的癌症和良性前列腺增生 (BPH) 等慢性疾病患者、人口老齡化更容易患此類疾病、產品開發的技術進步以及對微創的偏好由於趨勢的擴展，它已顯著增長。

泌尿裝置：市場動態

根據全球癌症觀察站（2024）提供的數據，2022年歐洲將有473,011例前列腺癌病例，亞洲將有386,424例，拉丁美洲和加勒比海地區（LAC）將有225,985例，美洲將有225,985例。

此外，亞洲有417,357例直腸癌，歐洲有181,701例，拉丁美洲和加勒比海地區有43,036例，非洲有27,672例。

根據美國國立衛生研究院(2024) 的數據，目前全球良性前列腺增生的盛行率正在上升，在60 多歲的人群中達到50-60%，在70 歲以上的人群中達到80- 90%。

此外，世界衛生組織（2021）指出，2015 年至 2050 年間，60 歲及以上人口數量將從 12% 至 22% 翻一番，到 2050 年達到 21 億。此外，據報道，到2030年，六分之一的人將超過60歲。

隨著人口老化，前列腺癌、良性前列腺增生、直腸癌的盛行率不斷增加，對泌尿器械產生了巨大的需求。這些疾病經常引起泌尿系統併發症，增加了對先進治療方案的需求。由於醫療技術的創新和對改善患者治療效果的日益關注，醫療保健系統正在優先考慮尿路阻塞的有效管理，這也有助於市場擴張。

按產品類型劃分，透析設備領域預計將在 2023 年佔據重要的收入佔有率。該行業的快速成長歸因於透析設備的特點。

先進的透析設備通常包括遠端監控功能、即時數據收集以及各種治療參數的自動化等功能，從而提高安全性和易用性。此外，對穿戴式透析設備的研究正在進行中，以增加患者的自由度並提高生活品質。透析設備的應用多種多樣，不僅用於慢性腎臟病管理，還用於急性腎損傷、藥物過量的緊急解毒，以及作為晚期腎臟病患者進行腎臟移植的橋樑。

按地區劃分，北美地區在 2023 年佔據市場主導地位，預計在預測期內將保持不變。這是由於腎結石的增加、前列腺癌患病率的增加以及對有效管理解決方案的需求不斷增長，而技術進步、監管批准以及領先企業對醫療基礎設施和創新產品開發的持續投資推動了這一趨勢。

本報告提供全球泌尿系統設備的市場調查，彙整市場概要，市場影響因素及市場機會分析，法律制度，市場規模的轉變·預測，各種區分·地區/各主要國家的詳細分析，競爭情形，主要企業簡介等資訊。

推動市場要素
- 慢性疾病增加
- 人口老化加劇
- 腎結石增加
- 人們對微創手術的興趣與日俱增
市場限制與課題
- 與血尿相關的周圍組織的破壞
- 殘留石塊的風險
市場機會
- 生物可吸收材料的開發
- 需要先進設備，消除診療不準確的困難

第6章泌尿系統設備市場:波特的五力分析

第7章泌尿系統設備市場評估

各產品類型
- 透析設備
- 內視鏡
- 尿動態系統
- 輸尿管支架
- 其他
各終端用戶
- 醫院
- 專門診所
各地區
- 北美
- 歐洲
- 亞太地區
- 其他地區

第8章泌尿系統設備市場:企業·產品簡介

Olympus Corporation
Baxter
Boston Scientific Corporation
B. Braun Melsungen AG
Nipro Corporation
Medtronic
Cook
BestMedical
Potent Medical
Laborie
Well Lead Medical Co.,Ltd
Amecath Medical Technologies
NIKKISO CO., LTD
Asahi Kasei Medical
Applied Medical Resources Corporation
Advin Urology
DirexGroup
STORZ MEDICAL AG
Richard Wolf GmbH
Fresenius Medical Care

第9章 KOL的見解

第10章計劃的方法

第11章關於DelveInsight

第12章免責聲明·聯絡方式

簡介目錄圖表

Product Code: DIMDCL0531

Urology Devices Market by Product Type (Dialysis Devices, Endoscopes [Ureteroscopes, Nephroscopes, Resectoscopes, and Others], Urodynamic Systems, Uretral Stents, and Others), End-User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2030 owing to the increasing cases of chronic disorders and the rising product developmental activities across the globe

The urology devices market was valued at USD 9.17 billion in 2023, growing at a CAGR of 6.78% during the forecast period from 2024 to 2030 to reach USD 13.56 billion by 2030. The urology devices market is growing significantly due to the increasing cases of chronic disorders including cancers and benign prostatic hyperplasia (BPH), rising geriatric population prone to such conditions, technological advancements in product development, growing preference of minimally invasive procedures that are expected to escalate the demand for urology devices during the forecast period from 2024 to 2030.

Urology Devices Market Dynamics:

According to the data provided by the Global Cancer Observatory (2024), in 2022, Europe accounted for 473,011 prostate cancer cases, Asia accounted for 386,424 prostate cancer cases, Latin American and the Caribbean (LAC) accounted for 225,985 prostate cancer cases, and Africa accounted for 103,050 prostate cancer cases.

Furthermore, it stated that Asia accounted for 417,357 rectum cancer cases, Europe accounted for 181,701 rectum cancer cases, LAC accounted for 43,036 rectum cancer cases, and Africa accounted for 27,672 rectum cancer cases.

According to the National Institute of Health (2024), the current prevalence of benign prostatic hyperplasia (BPH) is 50% to 60% for people in their 60s, increasing to 80% to 90% of those older than 70 years of age, globally.

Moreover, the World Health Organization (2021) further stated between 2015 and 2050, people falling between 60 years and above will be doubled from 12-22%, and will eventually reach 2.1 billion by the year 2050, globally. Moreover, by 2030, 1 in 6 people will be aged 60 years or above.

The increasing prevalence of prostate cancer, BPH, and rectal cancer, with aging populations, is creating a significant demand for urology devices. As these conditions often lead to urinary complications, the need for advanced treatment options is rising. The global aging trend, with more people reaching older age groups where these conditions are more common, further amplifies the market demand. Innovations in medical technology and a growing focus on improving patient outcomes are also contributing to the expansion of this market, as healthcare systems prioritize effective management of urinary tract obstructions.

Therefore, the factors stated above collectively will drive the overall urology devices market during the forecast period from 2024 to 2030.

However, the disruption of surrounding tissue associated with hematuria and risks of stone fragment retention, among others may limit their end-user base, thus acting as key constraints limiting the growth of the urology devices market.

Urology Devices Market Segment Analysis:

In the product type segment of urology devices, the dialysis devices category is expected to have a significant revenue share in the year 2023. The rapid growth of this product category can be attributed to the features of the dialysis devices.

Dialysis devices are essential medical equipment used to filter and purify blood for individuals whose kidneys can no longer perform these functions efficiently. The primary feature of dialysis devices is their ability to remove waste products, excess fluids, and toxins from the bloodstream, mimicking the natural functions of the kidneys.

Advanced dialysis machines often include features like remote monitoring capabilities, real-time data collection, and automation of various treatment parameters, enhancing safety and ease of use. Additionally, wearable dialysis devices are being explored to offer patients more freedom and improved quality of life. Applications of dialysis devices extend beyond chronic kidney disease management to include use in acute kidney injury, emergency detoxification for drug overdose cases, and as a bridge to kidney transplant for end-stage renal disease patients.

Therefore, owing to the above-mentioned factors, the demand for the dialysis devices category upsurges, thereby the category is expected to witness considerable growth eventually contributing to the overall growth of the urology devices market during the forecast period from 2024 to 2030.

North America is expected to dominate the overall urology devices market:

Among all the regions, North America is expected to dominate the urology devices market in the year 2023 and is expected to do the same during the forecast period from 2024 to 2030. This is due to the increasing instance of kidney stones, growing prevalence of prostate cancer underscoring the increased demand for effective management solutions, enhanced by technological advancements, regulatory approvals, and significant market presence of leading companies, continued investment in healthcare infrastructure and innovative product developments that are expected to drive the market for urology devices during the forecast period from 2024 to 2030.

According to the American Urological Association (2024), nearly 1 in 11 individuals in the US experience kidney stone at some point in their lives, and evidence suggests that the incidence of kidney stones is increasing.

According to Globocan (2024), in 2022, the US accounted for 230,125 cases of prostate cancer and Canada accounted for 25,560 cases of prostate cancer. Additionally, it further stated that by 2050, prostate cancer will reach to 346,000 cases in the North American region.

The rising incidence of kidney stones and prostate cancer is driving the demand for urology devices. As more individuals experience these conditions, there is a growing need for effective interventions to manage urinary blockages, making this a rapidly expanding market.

Additionally, in North America and at the global level the US represents the largest market worldwide supported by the developed healthcare infrastructure and strong adoption of technologically advanced products owing to the rise in healthcare expenditure by the government.

Rising product developmental activities by regulatory bodies in the region will further boost the market for urology devices. For example in April 2024, Olympus Corporation announced the FDA 510(k) clearance for its RenaFlex single-use ureteroscope system. RenaFlex offers access and visualization in the urinary tract to diagnose and treat urinary diseases and disorders, such as kidney stones.

Moreover, the presence of key players such as Boston Scientific Corporation, B. Braun Melsungen AG, Cook, among others in the region with their strong distribution networks ensure widespread availability and accessibility of these devices increasing their revenue shares in the market is also a driving factor for the urology devices market as they hold a significant revenue share in the region.

Therefore, the interplay of all the aforementioned factors above would provide a conducive growth environment for the North America region in the urology devices market.

Urology Devices Market key players:

Some of the key market players operating in the Urology Devices market include Olympus Corporation, Baxter, Boston Scientific Corporation, B. Braun Melsungen AG, Nipro Corporation, Medtronic, Cook, BestMedical, Potent Medical, Laborie, Well Lead Medical Co.,Ltd, Amecath Medical Technologies, NIKKISO CO., LTD, Asahi Kasei Medical, Applied Medical Resources Corporation, Advin Urology, DirexGroup, STORZ MEDICAL AG, Richard Wolf GmbH, Fresenius Medical Care, and others.

Recent Developmental Activities in the Urology Devices Market:

In January 2022, Applaud Medical, Inc received the Breakthrough Device designation from the U.S. Food and Drug Administration (FDA). The Acoustic Enhancer technology is designed to be used in conjunction with Ureteroscopy with Laser Lithotripsy (URS-LL).
In March 2021, Dornier MedTech GmbH became the world's first integrated urology company to be certified by the European Union's Medical Device Regulation (MDR). Dornier achieved the certification for its Class IIb products: Dornier Delta(R) III, one of the most powerful lithotripters that utilize Dornier's Extracorporeal Shock Wave Lithotripsy (ESWL) technology; and the Dornier UIMS(TM), a state-of-the-art information management software providing enhanced imaging and efficiency to support clinicians in treating kidney stones.
In January 2021, the US Food and Drug Administration granted the regulatory approval to Quanta Dialysis Technologies Ltd for their product- hemodialysis system SC+. The device is a portable system which is capable of offering dialysis care comparable to full-sized dialysis equipment in a range of care settings.

Key Takeaways from the Urology Devices Market Report Study

Market size analysis for current urology devices market size (2023), and market forecast for 6 years (2024 to 2030)
Top key product/services developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
Key companies dominating the urology devices market
Various opportunities available for the other competitors in the urology devices market space
What are the top-performing segments in 2023? How these segments will perform in 2030?
Which are the top-performing regions and countries in the current urology devices market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for urology devices market growth in the coming future?

Target audience who can be benefited from this Urology Devices Market Report Study

Urology devices product providers
Research organizations and consulting companies
Urology devices-related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and traders dealing in urology devices
Various end-users who want to know more about the urology devices market and the latest developments in the urology devices market

Frequently Asked Questions for the Urology Devices Market:

1. What are Urology Devices?

The urology devices encompass a variety of devices which are used in the treatment of indications specific to the urogenital systems. These devices include lithotripsy systems, urodynamic devices, and dialysis devices among others.

2. What is the market for Urology Devices?

The urology devices market was valued at USD 9.17 billion in 2023, growing at a CAGR of 6.78% during the forecast period from 2024 to 2030 to reach USD 13.56 billion by 2030.

3. What are the drivers for the Urology Devices market?

The urology devices market is growing significantly due to the increasing cases of chronic disorders including cancers and benign prostatic hyperplasia (BPH), rising geriatric population prone to such conditions, technological advancements in product development, growing preference of minimally invasive procedures are factors that are expected to escalate the demand for urology devices during the forecast period from 2024 to 2030.

4. Who are the key players operating in the Urology Devices market?

Some of the key market players operating in the urology devices market include Olympus Corporation, Baxter, Boston Scientific Corporation, B. Braun Melsungen AG, Nipro Corporation, Medtronic, Cook, BestMedical, Potent Medical, Laborie, Well Lead Medical Co., Ltd, Amecath Medical Technologies, NIKKISO CO., LTD, Asahi Kasei Medical, Applied Medical Resources Corporation, Advin Urology, DirexGroup, STORZ MEDICAL AG, Richard Wolf GmbH, Fresenius Medical Care, and others.

5. Which region has the highest share in the Urology Devices market?

Among all the regions, North America is estimated to hold a significant revenue share in the urology devices market. This is due to the increasing instances of kidney stones, and growing prevalence of prostate cancer underscoring the increased demand for effective management solutions, enhanced by technological advancements, regulatory approvals, and significant market presence of leading companies, continued investment in healthcare infrastructure, and innovative product developments that are expected to drive the market for urology devices during the forecast period from 2024 to 2030.

1. Urology Devices Market Report Introduction

1.1. Scope of the Study
1.2. Market Segmentation
1.3. Market Assumption

2. Urology Devices Market Executive Summary

2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

4.1. The United States
4.2. Europe
4.3. Japan
4.4. China

5. Urology Devices Market Key Factors Analysis

5.1. Urology Devices Market Drivers
- 5.1.1. Rising cases of chronic disorders
- 5.1.2. Growing geriatric population
- 5.1.3. Rising instances of kidney stones
- 5.1.4. Increasing preference for minimally invasive procedures
5.2. Urology Devices Market Restraints and Challenges
- 5.2.1. Disruption of surrounding tissue associated with hematuria
- 5.2.2. Risk of stone fragment retention
5.3. Urology Devices Market Opportunities
- 5.3.1. Development of bioresorbable materials
- 5.3.2. Need for advanced devices to eliminate inaccurate diagnosis and difficulties in treatment

6. Urology Devices Market Porter's Five Forces Analysis

6.1. Bargaining Power of Suppliers
6.2. Bargaining Power of Consumers
6.3. Threat of New Entrants
6.4. Threat of Substitutes
6.5. Competitive Rivalry

7. Urology Devices Market Assessment

7.1. By Product Type
- 7.1.1. Dialysis Devices
- 7.1.2. Endoscopes
  - 7.1.2.1. Ureteroscopes
  - 7.1.2.2. Nephroscopes
  - 7.1.2.3. Resectoscopes
  - 7.1.2.4. Others
- 7.1.3. Urodynamic Systems
- 7.1.4. Uretral Stents
- 7.1.5. Others
7.2. By End-User
- 7.2.1. Hospitals
- 7.2.2. Specialty Clinics
- 7.2.3. Others
7.3. By Geography
- 7.3.1. North America
  - 7.3.1.1. United States Urology Devices Market Size in USD million (2021-2030)
  - 7.3.1.2. Canada Urology Devices Market Size in USD million (2021-2030)
  - 7.3.1.3. Mexico Urology Devices Market Size in USD million (2021-2030)
- 7.3.2. Europe
  - 7.3.2.1. France Urology Devices Market Size in USD million (2021-2030)
  - 7.3.2.2. Germany Urology Devices Market Size in USD million (2021-2030)
  - 7.3.2.3. United Kingdom Urology Devices Market Size in USD million (2021-2030)
  - 7.3.2.4. Italy Urology Devices Market Size in USD million (2021-2030)
  - 7.3.2.5. Spain Urology Devices Market Size in USD million (2021-2030)
  - 7.3.2.6. Rest of Europe Urology Devices Market Size in USD million (2021-2030)
- 7.3.3. Asia-Pacific
  - 7.3.3.1. China Urology Devices Market Size in USD million (2021-2030)
  - 7.3.3.2. Japan Urology Devices Market Size in USD million (2021-2030)
  - 7.3.3.3. India Urology Devices Market Size in USD million (2021-2030)
  - 7.3.3.4. Australia Urology Devices Market Size in USD million (2021-2030)
  - 7.3.3.5. South Korea Urology Devices Market Size in USD million (2021-2030)
  - 7.3.3.6. Rest of Asia-Pacific Urology Devices Market Size in USD million (2021-2030)
- 7.3.4. Rest of the World (RoW)
  - 7.3.4.1. Middle East Urology Devices Market Size in USD million (2021-2030)
  - 7.3.4.2. Africa Urology Devices Market Size in USD million (2021-2030)
  - 7.3.4.3. South America Urology Devices Market Size in USD million (2021-2030)

8. Urology Devices Market Company and Product Profiles

8.1. Olympus Corporation
- 8.1.1. Company Overview
- 8.1.2. Company Snapshot
- 8.1.3. Financial Overview
- 8.1.4. Product Listing
- 8.1.5. Entropy
8.2. Baxter
- 8.2.1. Company Overview
- 8.2.2. Company Snapshot
- 8.2.3. Financial Overview
- 8.2.4. Product Listing
- 8.2.5. Entropy
8.3. Boston Scientific Corporation
- 8.3.1. Company Overview
- 8.3.2. Company Snapshot
- 8.3.3. Financial Overview
- 8.3.4. Product Listing
- 8.3.5. Entropy
8.4. B. Braun Melsungen AG
- 8.4.1. Company Overview
- 8.4.2. Company Snapshot
- 8.4.3. Financial Overview
- 8.4.4. Product Listing
- 8.4.5. Entropy
8.5. Nipro Corporation
- 8.5.1. Company Overview
- 8.5.2. Company Snapshot
- 8.5.3. Financial Overview
- 8.5.4. Product Listing
- 8.5.5. Entropy
8.6. Medtronic
- 8.6.1. Company Overview
- 8.6.2. Company Snapshot
- 8.6.3. Financial Overview
- 8.6.4. Product Listing
- 8.6.5. Entropy
8.7. Cook
- 8.7.1. Company Overview
- 8.7.2. Company Snapshot
- 8.7.3. Financial Overview
- 8.7.4. Product Listing
- 8.7.5. Entropy
8.8. BestMedical
- 8.8.1. Company Overview
- 8.8.2. Company Snapshot
- 8.8.3. Financial Overview
- 8.8.4. Product Listing
- 8.8.5. Entropy
8.9. Potent Medical
- 8.9.1. Company Overview
- 8.9.2. Company Snapshot
- 8.9.3. Financial Overview
- 8.9.4. Product Listing
- 8.9.5. Entropy
8.10. Laborie
- 8.10.1. Company Overview
- 8.10.2. Company Snapshot
- 8.10.3. Financial Overview
- 8.10.4. Product Listing
- 8.10.5. Entropy
8.11. Well Lead Medical Co.,Ltd
- 8.11.1. Company Overview
- 8.11.2. Company Snapshot
- 8.11.3. Financial Overview
- 8.11.4. Product Listing
- 8.11.5. Entropy
8.12. Amecath Medical Technologies
- 8.12.1. Company Overview
- 8.12.2. Company Snapshot
- 8.12.3. Financial Overview
- 8.12.4. Product Listing
- 8.12.5. Entropy
8.13. NIKKISO CO., LTD
- 8.13.1. Company Overview
- 8.13.2. Company Snapshot
- 8.13.3. Financial Overview
- 8.13.4. Product Listing
- 8.13.5. Entropy
8.14. Asahi Kasei Medical
- 8.14.1. Company Overview
- 8.14.2. Company Snapshot
- 8.14.3. Financial Overview
- 8.14.4. Product Listing
- 8.14.5. Entropy
8.15. Applied Medical Resources Corporation
- 8.15.1. Company Overview
- 8.15.2. Company Snapshot
- 8.15.3. Financial Overview
- 8.15.4. Product Listing
- 8.15.5. Entropy
8.16. Advin Urology
- 8.16.1. Company Overview
- 8.16.2. Company Snapshot
- 8.16.3. Financial Overview
- 8.16.4. Product Listing
- 8.16.5. Entropy
8.17. DirexGroup
- 8.17.1. Company Overview
- 8.17.2. Company Snapshot
- 8.17.3. Financial Overview
- 8.17.4. Product Listing
- 8.17.5. Entropy
8.18. STORZ MEDICAL AG
- 8.18.1. Company Overview
- 8.18.2. Company Snapshot
- 8.18.3. Financial Overview
- 8.18.4. Product Listing
- 8.18.5. Entropy
8.19. Richard Wolf GmbH
- 8.19.1. Company Overview
- 8.19.2. Company Snapshot
- 8.19.3. Financial Overview
- 8.19.4. Product Listing
- 8.19.5. Entropy
8.20. Fresenius Medical Care
- 8.20.1. Company Overview
- 8.20.2. Company Snapshot
- 8.20.3. Financial Overview
- 8.20.4. Product Listing
- 8.20.5. Entropy